Guerbet Diamond Sponsor at the 1st virtual ECIO

This year, and for the first time at this conference, healthcare professionals will experience our solutions for cTACE and targeted embolization directly from home. Last but not least, we are happy to host and welcome you to our live sessions and symposium.

Don't miss the chance to know more about our participation below! 👇

Interact with Prof. Geert Maleux

Interact with Prof. Geert Maleux

Attend a 30-minute interactive live session on Lymphangiography Technique with Prof. Geert Maleux (University Hospital Leuven, Belgium).

  • Saturday, April 10 / 12:30-13:00 CET
  • Saturday, April 10 / 16:00-16:30 CET
  • Monday, April 12 / 12:30-13:00 CET

💻 How to register?
Complete the form below to indicate your communication preferences and be redirected to the webinar registration page.

cTACE technical and clinical update

Live streaming symposium

cTACE technical and clinical update

Chairman: Prof. Thierry de Baere (Villejuif, France)

  • Why TACE must be super-selective : what we learn from Asian experience? - Prof. Thierry de Baere (Villejuif, France)
  • cTACE in HCC, EASL Guidelines evolution and importance of treatment standardization - Dr. Roman Kloeckner (Mainz, Germany)
  • cTACE & Immunotherapy an effective combination?
    Dr. Rafael Duran (Lausanne, Switzerland)

💻 Register for free   I   📅 Join the symposium

Explore our solutions 

Virtual Booth

Explore our solutions 

🏡 Online I From April 10th to 13th

Meet our experts to discover our global solutions for liver disease management as well as our product portfolio for better targeted embolizations on the ECIO virtual platform here.

Without a Scalpel Day “no surgery, no stitches, no scars“
Without a Scalpel Day “no surgery, no stitches, no scars“

Since Charles Dotter performed the very first angioplasty in 1964, the practice of Interventional Radiology has evolved significantly.

Hear from your peers on the evolution of interventional radiology

Additional indication for Lipiodol® Ultra-Fluid in South Africa
Additional indication for Lipiodol® Ultra-Fluid in South Africa

SAHPRA approves Lipiodol® Ultra-Fluid for visualization, localization and vectorization during TACE of intermediate-stage hepatocellular carcinoma in adults in South Africa.

Read the press release

Reducing the “everyday challenge” of non-target embolization
Reducing the “everyday challenge” of non-target embolization

Irene Bargellini (Pisa, Italy) tells that non-target embolization is a frequently under-diagnosed, sometimes fatal, problem that interventional radiologists encounter every time they work with embolics.

Watch the video

Want to learn more about our solutions?

Product registration and indication may vary from country to country, please refer to your local SmPC (Summary of Product Characteristics) or IFU (Instruction For Use).
I21000492